ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts7787
Avg. Estimate-0.56-0.48-1.83-0.61
Low Estimate-0.57-0.53-2.01-1.26
High Estimate-0.53-0.41-1.62-0.09
Year Ago EPS-0.72-0.55-2.36-1.83
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts7787
Avg. Estimate47.06M60.34M263.43M443.05M
Low Estimate46M56.46M257.13M330M
High Estimate48.3M64M271M543.48M
Year Ago Sales15.29M30.48M124.9M263.43M
Sales Growth (year/est)207.90%98.00%110.90%68.20%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.73-0.72-0.62-0.58
EPS Actual-0.72-0.55-0.53-0.55
Difference0.010.170.090.03
Surprise %1.40%23.60%14.50%5.20%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.56-0.48-1.83-0.61
7 Days Ago-0.56-0.48-1.83-0.61
30 Days Ago-0.56-0.48-1.83-0.61
60 Days Ago-0.52-0.45-1.73-0.67
90 Days Ago-0.54-0.47-1.74-0.7
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesACADIndustrySectorS&P 500
Current Qtr.22.20%N/AN/A0.42
Next Qtr.12.70%N/AN/A0.38
Current Year22.50%N/AN/A0.20
Next Year66.70%N/AN/A0.10
Next 5 Years (per annum)38.30%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A